3D-Printed candy pills could make medicine fun for kids
NCT ID NCT07424495
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will see if children and adolescents like chewable tablets made with a 3D printer. Researchers will test different flavors and sweetness levels to find the most acceptable ones. The goal is to create personalized, tasty medicines that kids will actually take, improving treatment adherence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
placebo chewable tablets produced by 3D printing
What this could lead to
If successful, this could lead to more child-friendly, personalized medicines that are easier and safer for kids to take.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to all children. It uses placebo tablets, not real medicine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALATABILITY ASSESSMENT OF 3D-PRINTED CHEWABLE TABLETS IN CHILDREN AND ADOLESCENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.